Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04982406 · ClinicalTrials.gov registry record
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 409
- Enrollment target
NCT04982406 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 409 participants.
The verdict
NCT04982406 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 409 participants
- Enrollment target
Study Summary
This is a prospective observational study, the purpose of which is to: 1. Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement. 2. Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction during placement of the valve prosthesis. 3. Correlate changes in AV nodal and infranodal conduction during the procedure with risk of developing AV conduction block after TAVR. 4. Assess the contribution of stressing the conduction system by atrial pacing prior to and following TAVR to prediction of postprocedural heart block. Assess the correlation between new onset bundle branch block, site and degree of conduction block or delay and subsequent development of high-grade or complete AV block.
Interventions
- DEVICE Transcatheter aortic valve replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2021-05-18 |
| Est. Completion | 2025-01-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04982406
The ClinicalTrials.gov registry entry for NCT04982406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcatheter aortic valve replacement is the first listed.
NCT04982406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04982406 about?
NCT04982406 is a clinical study titled "Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System". This is a prospective observational study, the purpose of which is to: 1. Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement. 2. Correlate preprocedure ECG features with changes in AV nodal and inf...
What is the current status of trial NCT04982406?
This trial is currently completed. The enrollment target is 409 participants. The study started on 2021-05-18. Estimated completion is 2025-01-21.
What interventions are being tested in trial NCT04982406?
The interventions under investigation include: Transcatheter aortic valve replacement (DEVICE).
Who is sponsoring clinical trial NCT04982406?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.